Alumni Nicole Friedland (Merrill ’89, community studies) and Brett King (Crown ’92, chemistry) both spoke at the National ...

Matthew Riccardi was just 11 years old when he was diagnosed with the same condition: alopecia areata, an autoimmune disorder ...

Alopecia areata and asthma are strongly linked, particularly through the inflammatory protein IL-33, suggesting a shared biological pathway and potential for targeted treatments like dupilumab.

In an alopecia areata trial, a novel bifunctional therapy that blocks signaling of the interleukin-7 and TSLP pathways produced impressive improvements in hair regrowth during and after therapy.

Alopecia areata can affect your emotional well-being and your quality of life. Some people even think about suicide. It's normal to be sad or angry when you have a condition that affects your self ...

Alopecia areata can make both your professional and personal life hard to navigate. Research has found that as many as 1 in 6 people are uncomfortable having contact with someone who has hair ...

Alopecia Areata Market Insights DelveInsight's Alopecia Areata Market report offers an in-depth understanding of the epidemiology and marke Tuesday, 02 January 2024 12:17 GMT عربي ...

Sy N, Mastacouris N, Strunk A, Garg A. Overall and racial and ethnic subgroup prevalences of alopecia areata, alopecia totalis, and alopecia universalis. JAMA Dermatol. 2023;159(4):419–423. doi ...

3. Stress Management. Stress can trigger alopecia areata symptoms, leading to more hair loss. You can incorporate stress management techniques into your day to help reduce stress and improve symptoms.

Alopecia areata is an autoimmune disease in which the body attacks the hair follicles. If you’re one of the 6.8 million people in the U.S. with this condition, what should you avoid with ...

“Very interestingly, there is, in the C3H mouse model of alopecia areata, demonstration that blockade of IL-7 can reverse alopecia areata.” King presented results from the SIGNAL-AA study, ...

It included 654 adults with severe alopecia areata (SALT score ≥50) who were randomized 3:2:2 to receive treatment with baricitinib 4 mg, baricitinib 2 mg, or placebo. Mean age was 37, and 58.6% ...